[Featured Stock] Dongwoon Anatech Tackles Diabetes with AI Semiconductor... National Project for Medical SoC Localization

Dongwoon Anatech is showing strong performance. The news that it has been selected as the lead research institution for the Ministry of Trade, Industry and Energy's national project, 'System Semiconductor Technology Development Project Linked to Demand for New Market Creation,' appears to be influencing its stock price.

As of 9:19 AM on the 6th, Dongwoon Anatech is trading at 29,000 KRW, up 16.47% from the previous day.

Dongwoon Anatech announced that it was selected as the lead research and development institution for the development of a saliva-based non-blood invasive diabetes sensor (strip) and a meter embedded with a system semiconductor integrating MCU and LDO, among other components. The joint research institutions include Seeas Technology and KETI (Korea Electronics Technology Institute), and the project duration is until December 31, 2025.

The project aims to ▲ develop medical system semiconductors (Dongwoon Anatech) ▲ jointly develop certain semiconductor design areas with KETI ▲ develop saliva diabetes measuring devices (meters) applying Dongwoon Anatech semiconductors ▲ jointly develop web-based applications for individuals and hospitals and AI-based postprandial blood glucose prediction algorithms with Seeas Technology.

The company explained, "The goal is to develop saliva diabetes measuring devices such as meters embedded with system semiconductors integrating a saliva-based non-blood invasive diabetes sensor (strip), MCU, and LDO." Dongwoon Anatech, a semiconductor design specialist company, will develop medical system semiconductors.

They will develop saliva diabetes measuring devices (meters) applying Dongwoon Anatech semiconductors and jointly develop web-based applications for individuals and hospitals, as well as AI-based postprandial blood glucose prediction algorithms with Seeas Technology.

It is expected to realize core bio system semiconductor components with proprietary technology. Through replacing imported system semiconductors in domestic bio & healthcare parts and module companies, localization and competitiveness enhancement are also anticipated. The goal is to achieve convenience and accuracy through non-blood invasive methods, and to miniaturize diagnostic systems and implement low-power systems by integrating multiple components into a single SoC when configuring diagnostic systems. The company explained that it expects to secure competitiveness in various sensor systems through the development of SoCs for microcurrent measurement and control.

This content was produced with the assistance of AI translation services.